Scinai Immunotherapeutics Ltd. (SCNI)
$1.18-2.48%Close
SELLCRISIS · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 2.13
- P/E (TTM)
- -0.00
- Short % float
- 1.80%
- Days to cover
- 1.0
- SI change
- -95.6%
- 1W
- -11.28%
- 1M
- -29.34%
- vs SPY 1W
- -12.44%
- vs SPY 1M
- -32.33%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SCNI?
- LOPJLB’s latest quantitative signal on Scinai Immunotherapeutics Ltd. (SCNI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SCNI in?
- Scinai Immunotherapeutics Ltd. (SCNI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Scinai Immunotherapeutics Ltd. (SCNI) do?
- Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions. The company maintains a significant licensing and collaboration agreement with the Max Planc…